Disease

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens Accuracy Metrics

Knolens harnesses proprietary AI algorithms to deliver industry-leading extraction precision of >99% and contextual accuracy exceeding 92% across life sciences data. Our platform ensures complete traceability to source documents, enabling confident decision-making with validated, transparent insights.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

What is Knolens KnolScapes?

Unified Intelligence for Strategic Drug Development

Knolscapes is an intelligence platform providing personalized, multi-dimensional analysis across therapeutic landscapes, diseases, and HTA assessments. It offers real-time, configurable analytics that integrate clinical, market, and competitive data to support cross-functional decision-making throughout drug development, saving thousands of hours and reducing costly missteps

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Accelerated intelligence: From siloed processes to synchronized decisions

By eliminating information silos and providing real-time, validated insights to all stakeholders simultaneously, Knolens reduces decision cycles from weeks to days.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

One truth, multiple perspectives: Precision insights that unify your organization

Knolens maintains a single source of truth with centralized data governance, ensuring all teams work from identical, validated information regardless of functional perspective

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Cross-functional intelligence: One platform, multiple perspectives, aligned decisions

Knolens creates a unified intelligence hub where cross-functional teams access the same verified insights, enabling seamless collaboration and aligned decision-making across departments

Cross Functional

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Risk Factors detailing how obesity relates to various health conditions

Knolens quantifies the economic impact of obesity-related conditions, strengthening your value proposition by demonstrating broader healthcare cost reductions.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
HEOR 

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

AI-Powered Systematic Literature Reviews with Regulatory Precision

Knolens SLR is an AI-powered platform that automates systematic literature reviews using the industry-standard PICOS methodology. It streamlines the entire SLR process from literature identification and screening to data extraction and synthesis, allowing researchers to efficiently conduct comprehensive reviews and test different hypotheses with full regulatory traceability.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Early Asset Evaluation

Knolens supports early-stage asset evaluation through comprehensive analysis of scientific, clinical, and market potential. The platform enables opportunity assessment using both historical analogs and predictive analytics.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Global market information of the particular study

Knolens analyzes market-specific factors, reimbursement timelines, and competitive dynamics to optimize your global launch strategy for maximum market penetration.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Market Access

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Safety concerns in Obesity trials

Knolens tracks and compares safety profiles across obesity treatments, identifying potential concerns early to inform risk mitigation strategies in your development program

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Clinical Development

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

How does KnolQuest help identify emerging treatment paradigms in metabolic disease and obesity?

KnolQuest analysis of emerging obesity treatment paradigms with evidence timeline.

KnolQuest analyzes scientific publications, clinical trials, and treatment guidelines to identify evolving approaches in obesity management. This intelligence helps you track GLP-1 innovations, emerging combination therapies, and shifting treatment algorithms—enabling strategic alignment with the rapidly evolving metabolic disease landscape. (39 words)

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Scientific findings from obesity treatment landscape

Knolens creates tailored scientific narratives with complete citation traceability, enabling medical science liaisons to engage confidently with KOLs using the latest evidence

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Safety concerns in Obesity trials

Knolens provides comprehensive safety profiles with supporting evidence from clinical trials and post-marketing data, enabling confident scientific exchange with healthcare professionals.

Knolscapes obesity biomarker pathway visualization with interconnected molecular targets.

Knolscapes creates interactive visualizations of obesity biomarker pathways like IGF axis and FoxO1, revealing molecular targets, genetic markers, and metabolic relationships. This comprehensive pathway mapping helps identify novel intervention points and prioritize promising therapeutic approaches for metabolic disorders

Medical Affairs

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Dropout rates for Obesity

Knolens analyzes pattern differences in competitor trial outcomes, including discontinuation rates and reasons, revealing potential competitive advantages and vulnerabilities.

Knolscape visualization GLP-1 agonists landscape for obesity treatment with drug comparison data.

Knolscapes visualizes competitive metabolic disease portfolios across development stages, revealing white space opportunities, abandoned indications, and potential licensing targets. This strategic intelligence helps you identify underserved patient populations and differentiation opportunities

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Competitive Intelligence

Choose your question from the below

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.

Early stage assets for obesity treatment

Knolens combines scientific, clinical, and commercial analysis to create comprehensive asset evaluations, supporting faster, more confident BD decisions.

Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Knolens delivers real-time intelligence across life sciences, accelerating decisions in R&D, clinical, regulatory, and commercial strategy.
Business Development